OTEZLA 10mg (Apremilast Tablet) 10mg, 20mg,30mg

OTEZLA (apremilast) is an oral tablet used for inflammatory conditions like psoriasis and psoriatic arthritis. This 10mg strength tablet is part of a broader treatment approach. Suitable for adults, it helps manage symptoms with a convenient dosing schedule.

Strength

10mg, 20mg,30mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Amgen Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OTEZLA (apremilast) is prescribed to reduce inflammation and symptoms associated with plaque psoriasis and active psoriatic arthritis. It is often used when other treatments have not been effective. The 10mg tablet is typically part of a step-up dosing regimen. Patients may also hear it described as a 'phosphodiesterase-4 inhibitor' for immune response modulation.

Side Effects

Many patients notice reduced joint pain and skin plaque severity after starting OTEZLA. Some experience mild gastrointestinal effects like nausea or diarrhea, especially early in treatment. These effects often lessen as the body adjusts to the medication. Weight loss and headache are also reported by some users.

Precautions & Warnings

Keep OTEZLA tablets at room temperature away from moisture and direct light. Store in the original packaging until ready to use. Avoid splitting or crushing the tablets unless directed. Keep out of reach of children and pets. If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose.

Avoid Interactions

OTEZLA may interact with strong CYP450 enzyme inducers like rifampin, reducing its effectiveness. Caution is advised when combining with other immune-modulating drugs. Alcohol use may increase the risk of side effects such as dizziness or stomach upset. Always inform your healthcare provider about all medications and supplements being taken.

Frequently Asked Questions

OTEZLA is used to treat plaque psoriasis and active psoriatic arthritis in adults.

Store OTEZLA at room temperature, away from moisture and direct light, in the original packaging.

Weight loss is a reported side effect for some users of OTEZLA.

OTEZLA may interact with certain drugs; consult a healthcare provider before combining medications.

Take the missed dose as soon as you remember, unless it is almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.